July 24, 2009
The FDA released the following statement this week regarding e-cigarettes:
Recent studies show e-cigarette vapors, inhaled by users, contain carcinogens and toxic chemicals.
The U.S. Food and Drug Administration (FDA) today announced that a laboratory analysis of electronic cigarette samples has found that they contain carcinogens and toxic chemicals such as diethylene glycol, an ingredient used in antifreeze.
Electronic cigarettes, also called “e-cigarettes,” are battery-operated devices that generally contain cartridges filled with nicotine, flavor and other chemicals. The electronic cigarette turns nicotine, which is highly addictive, and other chemicals into a vapor that is inhaled by the user. read more…
July 23, 2009
Download your own copy of the session summaries from the 2009 National Conference on Tobacco or Health. This PDF document is bookmarked; click on the subject matter that interests you to jump to that section of the document.
July 1, 2009
President Obama signs landmark legislation giving the Food and Drug Administration new power to regulate the tobacco industry.
Hello Arizona Partners in Tobacco Control,
Today the FDA announced it is seeking public Input on Tobacco Regulation:
The U.S. Food and Drug Administration announced today that it is seeking public input on the implementation of its historic new authority overseeing tobacco products in the United States. In a Federal Register notice, the agency invites the public to provide information and share views on a wide range of topics, from product content to advertising and marketing. All public comments will be posted online.
“We’re interested in receiving input from across the country as the FDA begins to implement this important new authority intended to reduce the enormous toll of suffering and death caused by tobacco products in the United States,” said Dr. Margaret A. Hamburg, Commissioner of Food and Drugs. “We look forward to the public’s response.”
Get more information about the FDA and tobacco regulation, read the Federal Register Notice, or review a timeline of key provisions of the FDA regulation. read more…